Mush­room mag­ic draws $80M in­jec­tion for Lon­don-based men­tal health start­up

The coro­n­avirus out­break has in­ter­fered with a mid-stage de­pres­sion tri­al test­ing its psilo­cy­bin com­pound, but the mag­ic of the mush­room has scored Pe­ter Thiel-backed Com­pass …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER